| Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX (NCT06353581) | Yonsei University | 2022-02-16 |
| Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC) (NCT07407231) | Institute of Oncology Ljubljana | 2021-09-01 |
| The Transformation of Locally Advanced Pancreatic Cancer. (NCT04723030) | Peking University | 2021-04-01 |
| Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY (NCT04789980) | Boryung Pharmaceutical Co., Ltd | 2021-01-29 |
| Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer (NCT03885219) | Peking Union Medical College Hospital | 2019-05-01 |
| Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer (NCT03815461) | Chinese Academy of Medical Sciences | 2019-02-01 |
| Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors (NCT03682289) | Rahul Aggarwal | 2019-01-17 |
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX (NCT03126435) | SynCore Biotechnology Co., Ltd. | 2018-10-16 |
| Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC) (NCT03648632) | Per Pfeiffer | 2018-08-22 |
| 2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy (NCT03468335) | AIO-Studien-gGmbH | 2018-03-31 |
| Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC (NCT03257033) | RenovoRx | 2018-03-12 |
| Divestment for Artery-involved Pancreatic Cancer (NCT03443921) | The First Affiliated Hospital with Nanjing Medical University | 2018-03-01 |
| Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer (NCT03600623) | University of Alabama at Birmingham | 2017-09-25 |
| FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial (NCT02578732) | Brown University | 2016-07-12 |
| Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy (NCT02404363) | Assistance Publique - Hôpitaux de Paris | 2016-01-11 |
| Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer (NCT02898649) | Yonsei University | 2015-12-01 |
| Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer (NCT01628458) | UMC Utrecht | 2012-09-01 |
| Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer. (NCT02035072) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2010-11-01 |
| Metformin Combined With Chemotherapy for Pancreatic Cancer (NCT01210911) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2010-08-01 |
| A Study of Locally Advanced Pancreatic Cancer (NCT01063192) | National Health Research Institutes, Taiwan | 2009-11-01 |
| Metastatic Advanced Pancreas Sorafenib (NCT00758381) | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | 2007-08-01 |
| Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma (NCT00744640) | University Hospital, Basel, Switzerland | 2005-10-01 |
| Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy (NCT00644618) | Huazhong University of Science and Technology | 2003-01-01 |
| Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial (NCT01795274) | University Hospital Heidelberg | |
| Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer (NCT01786850) | University of Roma La Sapienza | |